![Atsuko Watanabe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Atsuko Watanabe
Comptroller/Controller/Auditor en HanaVax, Inc. .
Perfil
Atsuko Watanabe is currently working as an Auditor at HanaVax, Inc. since 2018.
Previously, she worked as a Manager-Business Development at OncoTherapy Science, Inc. in 2019.
Cargos activos de Atsuko Watanabe
Empresas | Cargo | Inicio |
---|---|---|
HanaVax, Inc.
![]() HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01/11/2018 |
Antiguos cargos conocidos de Atsuko Watanabe.
Empresas | Cargo | Fin |
---|---|---|
ONCOTHERAPY SCIENCE, INC. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
HanaVax, Inc.
![]() HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Atsuko Watanabe